BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12650824)

  • 1. Infliximab for ulcerative colitis.
    Actis GC
    Am J Gastroenterol; 2003 Mar; 98(3):709. PubMed ID: 12650824
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab in the treatment of severe ulcerative colitis.
    Jiménez JM
    Rev Esp Enferm Dig; 2004 Feb; 96(2):89-93. PubMed ID: 15255017
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of ulcerative colitis with infliximab: are we there yet?
    Fuss IJ
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):247-9. PubMed ID: 15076622
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab for ulcerative colitis.
    Simmons J; Jewell DP
    Dig Liver Dis; 2002 Sep; 34(9):616-8. PubMed ID: 12405245
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab for ulcerative colitis.
    Chey WY; Shah A
    J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infliximab as treatment for a severe outbreak of ulcerative colitis].
    Ruiz P; San Salvador P; Ortiz de Zárate J; Cabezudo P; Marcé L; Polo F; Blanco S; Orive V
    Gastroenterol Hepatol; 2004; 27(7):430-1. PubMed ID: 15461945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ulcerative colitis associated with rectocolitis hemorrhagic: successful treatment with infliximab].
    Godart B; Beau P; Benchellal Z; Bumsel F; Metman E
    Gastroenterol Clin Biol; 2007 Jan; 31(1):88-90. PubMed ID: 17273137
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.
    Hendy P; Hart A
    Aliment Pharmacol Ther; 2015 Jan; 41(1):149. PubMed ID: 25483435
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab in ulcerative colitis: is there a placebo (effect) in the house?
    Cohen RD
    Gastroenterology; 2003 Jun; 124(7):1990-1; discussion 1991. PubMed ID: 12806639
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients.
    Santacana Juncosa E; Padullés Zamora A; Colom Codina H; Rodríguez Alonso L; Guardiola Capo J; Bas Minguet J; Padullés Zamora N
    Rev Esp Enferm Dig; 2016 Feb; 108(2):104-5. PubMed ID: 26838495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biologics treatment for ulcerative colitis].
    Nagahori M; Fujii T; Saito E; Ohtsuka K; Watanabe M
    Nihon Shokakibyo Gakkai Zasshi; 2013 Nov; 110(11):1909-15. PubMed ID: 24189818
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab or cyclosporine for severe ulcerative colitis.
    Hanauer SB
    Gastroenterology; 2005 Oct; 129(4):1358-9; author reply 1359. PubMed ID: 16230092
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of infliximab in ulcerative colitis: further questions.
    Lees CW; Shand AG; Penman ID; Satsangi J; Arnott ID
    Inflamm Bowel Dis; 2006 Apr; 12(4):335-7. PubMed ID: 16633056
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: The effects of preoperative infliximab on complications after surgery for ulcerative colitis.
    Yamamoto T
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1106-7; author reply 1107-8. PubMed ID: 23130779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ulcerative colitis and anti-TNFalpha].
    Nancey S; Moussata D; Flourié B
    Gastroenterol Clin Biol; 2007 Jan; 31(1):84-7. PubMed ID: 17273136
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab in refractory severe ulcerative colitis: a case report.
    Bossa F; Caserta L; Selvaggi F; Riegler G
    Minerva Gastroenterol Dietol; 2005 Sep; 51(3):261-2. PubMed ID: 16280968
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab therapy for ulcerative colitis: many unanswered questions.
    Present DH
    Am J Gastroenterol; 2001 Aug; 96(8):2294-6. PubMed ID: 11513164
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
    Halpin SJ; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450
    [No Abstract]   [Full Text] [Related]  

  • 19. Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
    Horai Y; Satoru O; Lapalme-Remis S; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Tamai M; Yamasaki S; Nakamura H; Takeshima F; Origuchi T; Kawakami A
    Mod Rheumatol; 2013 May; 23(3):572-6. PubMed ID: 22718488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
    Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
    Aliment Pharmacol Ther; 2011 Feb; 33(3):412-3. PubMed ID: 21198699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.